Recombinant Respiratory Syncytial Virus Pre-Fusion F Protein

Records for this ingredient, by country (identity only).

ATC — · 2 markets · 9 records

Recombinant Respiratory Syncytial Virus Pre-Fusion F Protein 2 markets · 9 records Forms
Filters
MarketAU 6FR 3
Kind

AU 6 records · 3 shown of 3 Source TGA、TGA CMI repository (consumer medic · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Only this ingredient

  • 0.12 mg per mL / per unit basis not statedinjectionAREXVY Recombinant Respiratory Syncytial Virus pre-fusion F protein vaccine 120 micrograms powder vial and suspension vial for suspension for unknown
  • 0.12 mgunknownAREXVY Recombinant Respiratory Syncytial Virus pre-fusion F protein vaccine 120 micrograms powder vial and suspension prefilled syringe for injection unknown

Combination products containing this ingredient

  • 0.12 mg per mL / per unit basis not statedinjection CombinationRecombinant Respiratory Syncytial Virus Pre-Fusion F Protein 0.12 mg + Water For Injections 0.65 mLABRYSVO recombinant respiratory syncytial virus pre-fusion F protein 120 microgram/0.5mL bivalent vaccine powder for injection vial and diluent syringeABRYSVO recombinant respiratory syncytial virus pre-fusion F protein 120 microgram/0.5mL bivalent vaccine powder for injection vial and diluent vial unknown
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名ABRYSVO ×2AREXVY ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

FR 3 records · 3 shown of 3 Source Base de données publique des médic · Data as of 2026-11-03

Only this ingredient

  • 0.12 mg/0.5 mLinjectionAREXVY, poudre et suspension pour suspension injectable. Vaccin du Virus Respiratoire Syncytial (VRS) (recombinant, avec adjuvant)
  • 0.06 mg/0.5 mLinjectionABRYSVO, poudre et solvant pour solution injectable. Vaccin du virus respiratoire syncytial (bivalent, recombinant)
  • 0.05 mg/0.5 mLinjectionMRESVIA, dispersion injectable en seringue préremplie. Vaccin à ARNm contre le virus respiratoire syncytial

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.